The United Laboratories International Holdings Limited (HKG:3933)

Market Cap	25.44B
Revenue (ttm)	14.64B
Net Income (ttm)	2.83B
Shares Out	1.82B
EPS (ttm)	1.56
PE Ratio	8.99
Forward PE	6.98
Dividend	0.59 (4.41%)
Ex-Dividend Date	Jul 8, 2025

Volume	22,547,616
Average Volume	19,758,484
Open	13.62
Previous Close	13.68
Day's Range	13.40 - 14.52
52-Week Range	7.84 - 16.96
Beta	0.15
RSI	53.52
Earnings Date	Mar 26, 2025

About HKG:3933

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 17,000
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3933

Financial Performance

In 2024, HKG:3933's revenue was 13.76 billion, an increase of 0.14% compared to the previous year's 13.74 billion. Earnings were 2.66 billion, a decrease of -1.54%.

Financial numbers in CNY